Open AccessEvaluation of butyrylcholinesterase and acetylcholinesterase activity in serum and saliva of myocardial infarction patients
Author(s) -
Neda Omidpanah,
Negin Jalilian,
Asad Vaisi-Raygani,
Masoud Sadeghi
Publication year - 2018
Publication title -
biomedical research and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 1
ISSN - 2198-4093
DOI - 10.15419/bmrat.v5i10.491
Subject(s) - butyrylcholinesterase , acetylcholinesterase , saliva , aché , medicine , myocardial infarction , cholinesterase , endocrinology , gastroenterology , immunology , enzyme , biochemistry , chemistry
Background: Myocardial infarction (MI) is one of the most common cardiovascular diseases. It accounts for about half of death cases in Iran. The objective of this study was to compare the activity of butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) enzymes in serum and saliva of the MI patients compared to the healthy controls.
Methods: Serum and salivary BChE and AChE levels were measured immediately following MI, and then 24 and 72 hours later. Four mL of blood and two mL saliva were collected for this purpose. These measurements were also collected in 30 healthy controls. The enzymes were assayed using spectrophotometry.
Results: The activity of salivary AChE in the MI patients was lower than that of the healthy controls right after, 24 hours, and 72 hours following MI. However, serum AChE did not show a significant difference between the two groups. The activity of serum BChE in the MI patients was lower than that of the healthy controls right after, 24 hours, and 72 hours following MI. However, salivary BChE did not show a significant difference between the two groups.
Conclusion: The activity of salivary AChE decreased in the MI patients compared to the healthy controls, which can be a marker to diagnose MI in the future.